KAREN E HUGHES
Physician Assistants & Advanced Practice Nursing Providers|Clinical Nurse Specialist LAFAYETTE, IN NPI 1902864036
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Clinical Nurse Specialist IN Astellas Pharma US Inc All categories
General Payments — all program years on this page
$3,036.47
- Category: General Payments
- Program years: PY2021–2024
- Record count: 106
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $773.98 across 28 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $575.98 | 26 |
| Education | $198.00 | 2 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Astellas Pharma US Inc | $215.91 | 3 |
| PFIZER INC. | $64.92 | 4 |
| Daiichi Sankyo Inc. | $55.31 | 2 |
| EISAI INC. | $51.84 | 2 |
| PharmaEssentia USA Corporation | $43.86 | 2 |
| Janssen Biotech, Inc. | $41.64 | 1 |
| Adaptive Biotechnologies Corporation | $29.08 | 1 |
| Gilead Sciences, Inc. | $28.02 | 1 |
| SERVIER PHARMACEUTICALS LLC | $26.29 | 1 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $22.31 | 1 |
| Karyopharm Therapeutics Inc. | $22.24 | 1 |
| PUMA BIOTECHNOLOGY, INC. | $21.27 | 1 |
| Agios Pharmaceuticals, Inc. | $21.09 | 1 |
| Acerta Pharma LLC | $20.82 | 1 |
| E.R. Squibb & Sons, L.L.C. | $20.66 | 1 |
| Pharmacosmos Therapeutics Inc. | $19.53 | 1 |
| SECURA BIO, INC. | $19.26 | 1 |
| ABBVIE INC. | $18.48 | 1 |
| Fennec Pharmaceuticals, Inc. | $16.17 | 1 |
| GlaxoSmithKline, LLC. | $15.28 | 1 |
By program year
Records — PY2024 (28)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.